MOJ Header

Ahead of Print Issue - March 2021, Volume 15, Issue No. 1

Official Journal of Malaysian Orthopaedic Association and ASEAN Orthopaedic Association

Fat Embolism Syndrome: A Qualitative Review of its Incidence, Presentation, Pathogenesis and Management

References

  1. Kosova E, Bergmark B, Piazza G. Fat embolism syndrome. Circulation. 2015; 131(3): 317-20. doi: 10.1161/CIRCULATIONAHA.114.010835
  2. Maitre S. Causes, clinical manifestations, and treatment of fat embolism. Virtual Mentor. 2006; 8(9): 590-2. doi: 10.1001/virtualmentor.2006.8.9.cprl1-0609
  3. White T, Petrisor BA, Bhandari M. Prevention of fat embolism syndrome. Injury. 2006; 37(Suppl 4): S59-67. doi: 10.1016/j.injury.2006.08.041
  4. Gurd AR. Fat embolism: an aid to diagnosis. J Bone Joint Surg Br. 1970; 52(4): 732-7.
  5. Gurd AR, Wilson RI. The fat embolism syndrome. J Bone Joint Surg Br. 1974; 56B(3): 408-16.
  6. Kwiatt ME, Seamon MJ. Fat embolism syndrome. Int J Crit Illn Inj Sci. 2013; 3(1): 64-8. doi: 10.4103/2229-5151.109426
  7. Lindeque BG, Schoeman HS, Dommisse GF, Boeyens MC, Vlok AL. Fat embolism and the fat embolism syndrome. A doubleblind therapeutic study. J Bone Joint Surg Br. 1987; 69(1): 128-31. doi: 10.1302/0301-620X.69B1.3818718
  8. Schonfeld SA, Ploysongsang Y, DiLisio R, Crissman JD, Miller E, Hammerschmidt DE, et al. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. 1983; 99(4): 438-43. doi: 10.7326/0003-4819-99-4-438
  9. Muller C, Rahn BA, Pfister U, Meinig RP. The incidence, pathogenesis, diagnosis, and treatment of fat embolism. Orthop Rev. 1994;23(2):107-17.
  10. Laub DR, Jr., Laub DR. Fat embolism syndrome after liposuction: a case report and review of the literature. Ann Plast Surg. 1990; 25(1): 48-52. doi: 10.1097/00000637-199007000-00011
  11. Mendoza-Morales R, Camberos-Nava E, Luna-Rosas A, Garcés-Ramírez L, De la Cruz F, García-Dolores F. A fatal case of systemic fat embolism resulting from gluteal injections of vitamin e for cosmetic enhancement. Forensic Sci Intl. 2016; 259: e1-4. doi: 10.1016/j.forsciint.2015.11.012
  12. Tsitsikas DA, Gallinella G, Patel S, Seligman H, Greaves P, Amos RJ. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. Blood Rev. 2014; 28(1): 23-30. doi: 10.1016/j.blre.2013.12.002.
  13. Bulger EM, Smith DG, Maier RV, Jurkovich GJ. Fat embolism syndrome. A 10-year review. Arch Surg. 1997; 132(4): 435-9. doi: 10.1001/archsurg.1997.01430280109019
  14. Robert JH, Hoffmeyer P, Broquet PE, Cerutti P, Vasey H. Fat embolism syndrome. Orthop Rev. 1993; 22(5): 567-71.
  15. Fabian TC, Hoots AV, Stanford DS, Patterson CR, Mangiante EC. Fat embolism syndrome: prospective evaluation in 92 fracture patients. Crit Care Med. 1990; 18(1): 42-6.
  16. Kim YH. Incidence of fat embolism syndrome after cemented or cementless bilateral simultaneous and unilateral total knee arthroplasty. J Arthroplasty. 2001; 16(6): 730-9. doi: 10.1054/arth.2001.23723.
  17. Pell AC, Hughes D, Keating J, Christie J, Busuttil A, Sutherland GR. Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med. 1993; 329(13): 926-9. doi: 10.1056/NEJM199309233291305
  18. DeFroda SF, Klinge SA. Fat Embolism Syndrome With Cerebral Fat Embolism Associated With Long-Bone Fracture. Am J Orthop (Belle Mead NJ). 2016; 45(7): E515-E21.
  19. Hayes I, Walshe C, Kossmann T, Iles L, Cooper J. Cerebral fat embolism syndrome causing brain death after long bone fractures and acetazolamide therapy. Crit Care Resusc. 2007; 9(2): 184.
  20. Fernandez-Torre JL, Burgueno P, Ballesteros MA, Hernandez-Hernandez MA, Villagra-Teran N, de Lucas EM. Super-refractory nonconvulsive status epilepticus secondary to fat embolism: A clinical, electrophysiological, and pathological study. Epilepsy Behav. 2015; 49: 184-8. doi: 10.1016/j.yebeh.2015.04.045
  21. Scopa M, Magatti M, Rossitto P. Neurologic symptoms in fat embolism syndrome: case report. J Trauma. 1994; 36(6): 906-8. doi: 10.1097/00005373-199406000-00030
  22. Jacobson DM, Terrence CF, Reinmuth OM. The neurologic manifestations of fat embolism. Neurology. 1986; 36(6): 847-51. doi: 10.1212/wnl.36.6.847
  23. Shaikh N. Emergency management of fat embolism syndrome. J Emerg Trauma Shock. 2009; 2(1): 29-33. doi: 10.4103/0974-2700.44680
  24. Parizel PM, Demey HE, Veeckmans G, Verstreken F, Cras P, Jorens PG, et al. Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern). Stroke. 2001; 32(12): 2942-4.
  25. Tachakra SS. Distribution of skin petechiae in fat embolism rash. Lancet. 1976; 1(7954): 284-5. doi: 10.1016/s0140-6736(76)91408-2
  26. Jaffe FA. Petechial Hemorrhages A Review of Pathogenesis. Am J Forensic Med Pathol. 1994; 15(3): 203-7. doi: 10.1097/00000433-199409000-00004
  27. Nentwich MM, Remy M, Schaller UC. Ocular fat embolism syndrome. Int Ophthalmol. 2011; 31(1): 15-6. doi: 10.1107/s10792-010-9378-8
  28. Agrawal A, McKibbin MA. Purtscher's and Purtscher-like retinopathies: a review. Surv Ophthalmol. 2006; 51(2): 129-36. doi: 10.1016/j.survophthal.2005.12.003
  29. Riseborough EJ, Herndon JH. Alterations in pulmonary function, coagulation and fat metabolism in patients with fractures of the lower limbs. Clin Orthop Relat Res. 1976; (115): 248-67.
  30. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996; 87(6): 2573-8.
  31. Ross AP. The value of serum lipase estimations in the fat embolism syndrome. Surgery. 1969; 65(2): 271-3.
  32. Chastre J, Fagon JY, Soler P, Fichelle A, Dombret MC, Huten D, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med. 1990; 113(8): 583-8. doi: 10.7326/003-4819-113-8-583
  33. Godeau B, Schaeffer A, Bachir D, Fleury-Feith J, Galacteros F, Verra F, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med. 1996; 153(5): 1691-6. doi: 10.1164/ajrccm.153.5.8630622
  34. Mimoz O, Edouard A, Beydon L, Quillard J, Verra F, Fleury J, et al. Contribution of bronchoalveolar lavage to the diagnosis of posttraumatic pulmonary fat embolism. Intensive Care Med. 1995; 21(12): 973-80. doi: 10.1007/BF01700658.
  35. Vedrinne JM, Guillaume C, Gagnieu MC, Gratadour P, Fleuret C, Motin J. Bronchoalveolar lavage in trauma patients for diagnosis of fat embolism syndrome. Chest. 1992; 102(5): 1323-7. doi: 10.1378/chest.102.5.1323.
  36. Jones JG, Minty BD, Beeley JM, Royston D, Crow J, Grossman RF. Pulmonary epithelial permeability is immediately increased after embolisation with oleic acid but not with neutral fat. Thorax. 1982; 37(3): 169-74. doi: 10.1136/thx.37.3.169
  37. Roger N, Xaubet A, Agusti C, Zabala E, Ballester E, Torres A, et al. Role of bronchoalveolar lavage in the diagnosis of fat embolism syndrome. Eur Respir J. 1995; 8(8): 1275-80. doi: 10.1183/09031936.95.08081275
  38. Erdem E, Namer IJ, Saribas O, Aras T, Tan E, Bekdik C, et al. Cerebral fat embolism studied with MRI and SPECT. Neuroradiology. 1993;35(3):199-201. doi: 10.1007/BF00588493
  39. Takahashi M, Suzuki R, Osakabe Y, Asai JI, Miyo T, Nagashima G, et al. Magnetic resonance imaging findings in cerebral fat embolism: correlation with clinical manifestations. J Trauma. 1999; 46(2): 324-7. doi: 10.1097/00005373-199902000-00021
  40. Suzuki S, Hayashi T, Ri K, Hashimoto T, Matsui S, Kitanosono T, et al. Brain CT and MRI findings in fat embolism syndrome. Nihon Igaku Hoshasen Gakkai Zasshi. 1996; 56(6): 390-8.
  41. Kuo KH, Pan YJ, Lai YJ, Cheung WK, Chang FC, Jarosz J. Dynamic MR imaging patterns of cerebral fat embolism: a systematic review with illustrative cases. AJNR Am J Neuroradiol. 2014; 35(6): 1052-7. doi: 10.3174/ajnr.A3605
  42. Newbigin K, Souza CA, Torres C, Marchiori E, Gupta A, Inacio J, et al. Fat embolism syndrome: State-of-the-art review focused on pulmonary imaging findings. Respir Med. 2016;113:93-100. doi: 10.1016/j.rmed.2016.01.018
  43. Nolte WJ, Olofsson T, Schersten T, Lewis DH. Evaluation of the Gurd test for fat embolism. J Bone Joint Surg Br. 1974; 56B(3): 417-20.
  44. Gauss H. The pathology of fat embolism. Arch Surg. 1924; 9(3): 593-605. doi: 10.1001/archsurg.1924.01120090110007
  45. Husebye EE, Lyberg T, Roise O. Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. Injury. 2006; 37(Suppl 4): S8-18. doi: 10.1016/injury.2006.08.036.
  46. Pell AC, Christie J, Keating JF, Sutherland GR. The detection of fat embolism by transoesophageal echocardiography during reamed intramedullary nailing. A study of 24 patients with femoral and tibial fractures. J Bone Joint Surg Br. 1993; 75(6): 921-5. doi: 10.1302/0301-620X.75B6.8245083
  47. Lehman EP, Moore RM. Fat embolism: including experimental production without trauma. Arch Surg. 1927; 14(3): 621-62. doi: 10.1001/archsurg.1927.01130150002001
  48. Peltier LF. Fat embolism. III. The toxic properties of neutral fat and free fatty acids. Surgery. 1956; 40: 665-70.
  49. Liu DD, Hsieh NK, Chen HI. Histopathological and biochemical changes following fat embolism with administration of corn oil micelles: a new animal model for fat embolism syndrome. J Bone Joint Surg Br. 2008; 90(11): 1517-21. doi: 10.1302/0301-620X.90B11.20761
  50. Poisner A, Herndon B, Lankachandra K, Likhitsup A, Al Hariri A, Kesh S, et al. Fat embolism sensitizes rats to a "second hit" with lipopolysaccharide: An animal model of pulmonary fibrosis. J Trauma Acute Care Surg. 2015; 78(3): 552-7. doi: 10.1097/TA.0000000000000539
  51. Agre P. The aquaporin water channels. Proc Am Thorac Soc. 2006; 3(1): 5-13. doi: 10.1513/pats.200510-109JH
  52. Zhang Y, Tian K, Wang Y, Zhang R, Shang J, Jiang W, et al. The Effects of Aquaporin-1 in Pulmonary Edema Induced by Fat Embolism Syndrome. Int J Mol Sci. 2016; 17(7): 1183 doi: 10.3390/ijms17071183
  53. Kokatnur MG, Oalmann MC, Johnson WD, Malcom GT, Strong JP. Fatty acid composition of human adipose tissue from two anatomical sites in a biracial community. Am J Clin Nutr. 1979; 32(11): 2198-205. doi: 10.1093/acjn/32.11.2198
  54. Vadasz I, Morty RE, Kohstall MG, Olschewski A, Grimminger F, Seeger W, et al. Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? Am J Respir Crit Care Med. 2005; 171(5): 469-79. doi: 10.1164/rccm.200407-9540C
  55. Goodman DS. The interaction of human serum albumin with long-chain fatty acid anions. J Am Chem Soc. 1958; 80(15): 3892-8. doi: 10.1021/ja01548a024
  56. Moylan JA, Birnbaum M, Katz A, Everson MA. Fat emboli syndrome. J Trauma. 1976; 16(5): 341-7. doi: 10.1097/00005373-197605000-00002.
  57. Mogensen KM, Robinson MK, Casey JD, Gunasekera NS, Moromizato T, Rawn JD, et al. Nutritional Status and Mortality in the Critically Ill. Crit Care Med. 2015; 43(12): 2605-15. doi: 10.1097/CCM.0000000000001306
  58. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2012; (6): CD000567. doi: 10.1002/14651858.CD000567.pub6
  59. Amanullah S, Venkataraman R. The routine use of albumin for fluid resuscitation of critically ill patients is not warranted. Crit Care. 2004; 8: E2. doi: 10.1186/cc3006
  60. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest. 2007; 131(3): 913-20. doi: 10.1378/chest.06-1743
  61. Uhlig C, Silva PL, Deckert S, Schmitt J, de Abreu MG. Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2014; 18(1): R10. doi: 10.1186/cc13187
  62. Fletcher AN, Molteni A, Ponnapureddy R, Patel C, Pluym M, Poisner AM. The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism. J Trauma Acute Care Surg. 2017; 82(2): 338-44. doi: 10.1097/TA.0000000000001278
  63. Poisner A, Herndon B, Bass D, Jain A, Fletcher A, Molteni A. Losartan protects the lung from chronic cellular damage induced by fat embolism (LB512). The FASEB Journal. 2014; 28(1): LB512. doi: 10.1096/fasebj.28.1_supplement.lb512
  64. Lewis A, Pappas Am. Experimental fat embolism: evaluation of treatment with low molecular weight dextran. J Trauma Acute Care Surg. 1969; 9(1): 49-55.
  65. Sage R, Tudor R. Treatment of fat embolism with heparin. British Med J. 1958; 1(5080): 1160. doi: 10.1136/bmj.1.5080.1160
  66. Kallenbach J, Lewis M, Zaltzman M, Feldman C, Orford A, Zwi S. 'Low-dose' corticosteroid prophylaxis against fat embolism. J Trauma. 1987; 27(10): 1173-6.
  67. Bederman SS, Bhandari M, McKee MD, Schemitsch EH. Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis. Can J Surg. 2009; 52(5): 386-93.
  68. Tasker A, Kelly M. Managing trauma: the evolution from ‘early total care’/‘damage control’to ‘early appropriate care’. JTO. 2014; 2(2): 66-70.
  69. Pape HC. Effects of changing strategies of fracture fixation on immunologic changes and systemic complications after multiple trauma: damage control orthopedic surgery. J Orthop Res. 2008; 26(11): 1478-84. doi: 10.1002/jor.20697
  70. Tanton J. L’embolie graisseuse traumatique. J de Chir. 1914; 12: 287-96.
  71. Riska EB, von Bonsdorff H, Hakkinen S, Jaroma H, Kiviluoto O, Paavilainen T. Prevention of fat embolism by early internal fixation of fractures in patients with multiple injuries. Injury. 1976; 8(2): 110-6. doi: 10.1016/0020-1383(76)-90043-772.
  72. Bone LB, Johnson KD, Weigelt J, Scheinberg R. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J Bone Joint Surg Am. 1989; 71(3): 336-40.
  73. Behrman SW, Fabian TC, Kudsk KA, Taylor JC. Improved outcome with femur fractures: early vs. delayed fixation. J Trauma. 1990; 30(7): 792-7. doi: 10.1097/00005373-199007000-00005
  74. Brundage SI, McGhan R, Jurkovich GJ, Mack CD, Maier RV. Timing of femur fracture fixation: effect on outcome in patients with thoracic and head injuries. J Trauma. 2002; 52(2): 299-307. doi: 10.1097/00005373-200202000-00016
  75. Pinney SJ, Keating JF, Meek RN. Fat embolism syndrome in isolated femoral fractures: does timing of nailing influence incidence? Injury. 1998; 29(2): 131-3. doi: 10.1016/s0020-1383(97)00154-x
  76. Bick EM. The intramedullary Nailing of Fractures by G. Kuntscher. Translation of article in Archiv fur Klinische Chirurgie, 200:443,1940. Clin Orthop Relat Res. 1968; 60: 5-12.
  77. Kropfl A, Berger U, Neureiter H, Hertz H, Schlag G. Intramedullary pressure and bone marrow fat intravasation in unreamed femoral nailing. J Trauma. 1997; 42(5): 946-54. doi: 10.1097/00005373-199705000-00028
  78. Pitto RP, Koessler M, Kuehle JW. Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty. A prospective, randomized clinical trial. J Bone Joint Surg Am. 1999; 81(6): 831-43. doi: 10.2106/00004623-199906000-00010
  79. Volgas DA, Burch T, Stannard JP, Ellis T, Bilotta J, Alonso JE. Fat embolus in femur fractures: a comparison of two reaming systems. Injury. 2010;41(Suppl 2):S90-3. doi: 10.1016/S0020-1383(10)70017-6
  80. Baig MN, Curtin W. A Simple and Easy Intramedullary Lavage Method to Prevent Embolism During and After Reamed Long Bone Nailing. Cureus. 2017;9(8):e1609. doi: 10.7759.cures.1609
  81. Zhao J, Zhang J, Ji X, Li X, Qian Q, Xu Q. Does intramedullary canal irrigation reduce fat emboli? A randomized clinical trial with transesophageal echocardiography. J Arthroplasty. 2015;30(3):451-5. doi: 10.1016/j.arth.2014.10.006
  82. Müller C, Frigg R, Pfister U. Effect of flexible drive diameter and reamer design on the increase of pressure in the medullary cavity during reaming. Injury. 1993;24:S40-S7. doi: 10.1016/0020-1383(93)90006-r
  83. Habashi NM, Andrews PL, Scalea TM. Therapeutic aspects of fat embolism syndrome. Injury. 2006;37(Suppl 4):S68-73. doi: 10.1016/j.injury.2006.08.042
  84. Binkowska AM, Michalak G, Slotwinski R. Current views on the mechanisms of immune responses to trauma and infection. Cent Eur J Immunol. 2015;40(2):206-16. doi: 10.5114/ceji.2015.52835
  85. Butteriss DJ, Mahad D, Soh C, Walls T, Weir D, Birchall D. Reversible cytotoxic cerebral edema in cerebral fat embolism. AJNR Am J Neuroradiol. 2006;27(3):620-3.
  86. Sie MY, Toh KW, Rajeev K. Cerebral fat embolism: an indication for ICP monitor? J Trauma. 2003;55(6):1185-6. doi: 10.1097/01.TA.0000100833.57027.1F
  87. Georgopoulos D, Bouros D. Fat embolism syndrome: clinical examination is still the preferable diagnostic method. Chest. 2003;123(4):982-3. doi: 10.1378/chest.123.4.982
  88. Bullock R, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, et al. Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med. 1996;3(2):109-27.

Abstract   |   Reference

MOJ footer

About Us

The Malaysian Orthopaedic Journal is a peer-reviewed journal that is published three times a year in both print and electronic online version. The purpose of this journal is to publish original research studies, evaluation of current practices and case reports in various subspecialties of orthopaedics and traumatology, as well as associated fields like basic science, biomedical engineering, rehabilitation medicine and nursing.

Keep in Touch

creative-commons License